Successful risperidone treatment for behavioral disturbances in Prader-Willi syndrome.
Araki
Shunsuke
S
Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Japan. arashun@med.uoeh-u.ac.jp
Ohji
Taro
T
Shiota
Naoki
N
Dobashi
Kazushige
K
Shimono
Masayuki
M
Shirahata
Akira
A
D000374:Aggression / Q000187:drug effects / Q000523:psychology; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects; D002648:Child; D002653:Child Behavior Disorders / Q000188:drug therapy* / Q000523:psychology*; D002872:Chromosome Deletion; D002884:Chromosomes, Human, Pair 15 / Q000235:genetics; D015928:Cognitive Behavioral Therapy / Q000379:methods; D003131:Combined Modality Therapy; D004038:Diet, Reducing / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D011218:Prader-Willi Syndrome / Q000188:drug therapy* / Q000235:genetics / Q000523:psychology*; D018967:Risperidone / Q000009:adverse effects / Q000627:therapeutic use*; D014754:Violence / Q000517:prevention & control / Q000523:psychology
D014150:Antipsychotic Agents; D018967:Risperidone